Morpholino
MO2-gaa
- ID
- ZDB-MRPHLNO-200918-2
- Name
- MO2-gaa
- Previous Names
-
- I9E10gaa-MO (1)
- Target
- Sequence
-
5' - ATGTCCTGTAAACAAGAAAATCACA - 3'
- Disclaimer
- Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
- Note
- None
- Genome Resources
- None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-gaa
No data available
Phenotype
Phenotype resulting from MO2-gaa
1 - 5 of 20 Show all
Phenotype of all Fish created by or utilizing MO2-gaa
1 - 5 of 32 Show all
Citations
- Cinzia, B., Flavia, B., Gary, I., Renato, M., Lorenzo, M. (2021) Therapeutic efficacy of 3,4-Diaminopyridine phosphate on neuromuscular junction in Pompe disease. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 137:111357
- Bragato, C., Carra, S., Blasevich, F., Salerno, F., Brix, A., Bassi, A., Beltrame, M., Cotelli, F., Maggi, L., Mantegazza, R., Mora, M. (2020) Glycogen storage in a zebrafish Pompe disease model is reduced by 3-BrPA treatment. Biochimica et biophysica acta. Molecular basis of disease. 1866(5):165662
1 - 2 of 2
Show